RLY-2608

RLY-2608 : Allosteric Inhibitor of PIK3CA

Structure

Information

  • PIK3CA (Mutant:WT, H1047R, E542K, E545K)
  • Allosteric
  • up to 100 nM

In Vitro Validations

Uniprot ID: P42336
Target Class: Kinase
Target SubClass: PI3/PI4-kinase
Potency: IC50
Potency Value: 4 nM
Potency Assay: Biochemical assay using H1047R mutant
PDB ID for probe-target interaction (3D structure): 8TSD
Target aliases:
Phosphatidylinositol 4,5-bisphosphate 3-kinase cat ...

DOI Reference: 10.1158/2159-8290.CD-23-0944

Uniprot ID: P42336
Target Class: Kinase
Target SubClass: PI3/PI4-kinase
Potency: IC50
Potency Value: 48 nM
Potency Assay: Biochemical assay using WT protein
PDB ID for probe-target interaction (3D structure): 8TSD
Target aliases:
Phosphatidylinositol 4,5-bisphosphate 3-kinase cat ...

DOI Reference: 10.1158/2159-8290.CD-23-0944

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay (off target): In vitro kinome profile of RLY-2608. RLY-2608 was tested at a concentration of 10 μM by SelectScreen
Potency assay, off target (cells): tested on various cells lines for target engagement and cell proliferation
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

Clinically active compound with a >10-fold window to PI3Ka WT. Highly selective for the alpha isoform. Quality tool.

(last updated: 7 Jan 2025 )